Dose and scanning delay using USPIO for central nervous system macrophage imaging |
| |
Authors: | Vincent Dousset Christophe Gomez Klaus G Petry Christophe Delalande Jean-Marie Caille |
| |
Affiliation: | (1) Laboratoire de Neurobiologie et Neuroimagerie Expérimentales, Université Victor Segalen Bordeaux 2, Rue Léo-Saignat, BP 78, 33076 Bordeaux, France;(2) Laboratoire de Neurobiologie Intégrative, INSERM 394, I rue Camille Saint Sa'ns, 33077 Bordeaux, France;(3) Laboratoire de Résonance Magnétique des Systèmes Biologiques, CNRS/Université Victor Segalen Bordeaux 2, 33076 Bordeaux, France |
| |
Abstract: | Rationale and objectives: In experimental allergic encephalomyelitis (EAE), central nervous system (CNS) macrophage imaging is achievable by MRI using
AMI-227 an ultra-small particle iron oxide contrast agent at a dose of 300 μmol/kg Fe. The objective was to test the feasibility
at the human recommended dose of 45 μmol/kg Fe.Methods: Two groups of EAE rats were tested with AMI-227 using 45 and 300 μmol/kg Fe respectively. Following i.v. injection of AMI-227,
they were scanned after a delay of 4–6 and 20–24 h.Results: With a high dose of AMI-227, all animals showed low signal intensity related to iron-loaded macrophages in the CNS. At low
dose no abnormalities were found in the CNS. Furthermore, a delay of 4–6 h failed to demonstrate abnormalities even at high
dose.Conclusions: Dose, scanning delay after administration and blood half-life are major parameters for T2* CNS macrophage imaging. |
| |
Keywords: | MRI Allergic encephalomyelitis Macrophages Contrast agents |
本文献已被 SpringerLink 等数据库收录! |
|